BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Solulink, Inc. Appoints Life Science Industry Veteran Jack Ball as Chief Executive Officer


9/11/2013 7:16:03 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Solulink Appoints Life Science Industry Veteran Jack Ball as Chief Executive Officer

San Diego, CA, September 10, 2013 – Solulink, Inc., an emerging life science tools company with expertise in biomolecular linking, announced today that Jack Ball has been appointed as the company’s Chief Executive Officer. A proven performer, Mr. Ball will lead the company as it commercializes its HybriLink™ technology.

The HybriLink technology solves the ‘missing color’ problem: the inability to find the needed antibody labeled with the right fluorophore (color). Often, the desired combination is not commercially available. By providing a simple way to mix and match any fluorophore with any antibody on demand, just-in-time at the point-of-use, HybriLink dramatically streamlines the development and expansion of multicolor flow panels for flow cytometry research labs. Solulink believes that HybriLink’s ability to offer all antibodies in all fluorophores – including the next generation of emerging fluorophores – resolves a fundamental challenge in flow cytometry and will expand the overall flow cytometry reagents market size. The HybriLink technology also provides increased flexibility in antibody labeling to the microscopy, western blot and ELISA markets.

Mr. Ball brings a solid track record of life sciences leadership with a strong background in commercial operations, and extensive experience in the life science markets. Most recently, he served as Chief Commercial Officer at Accuri Cytometers, Inc., before its acquisition by BD Biosciences in 2011. Prior to joining Accuri, Mr. Ball was CEO of Amnis Corporation, a venture-backed, technology start-up developing high-end imaging flow cytometers. He also served as Chief Commercial Officer for Molecular Probes, Inc. (now a part of Life Technologies), the world leader in reagents for molecular biology and cell analysis. Before that, Mr. Ball was the Senior VP & General Manager of the Life Sciences Group at Orchid Biosciences, and a senior executive at Amersham Pharmacia Biotech Inc., where he rose to President, North America, and was responsible for sales, marketing, and customer support.

In addition to Solulink, Mr. Ball serves on the board of directors of 3D Biomatrix, IntelliCyt, RealBio Technology, Swift Bioscience and ViroCyt as well as the non-profit organization, the Association of Commercial Professionals - Life Sciences (ACP-LS).

“We are very pleased to welcome Jack as Solulink’s new CEO,” said Walt Young, Solulink’s Chairman of the Board. “Jack brings an impressive executive track record of success and major accomplishments in flow cytometry and the life sciences, and was directly responsible for driving growth in hundred million dollar businesses. His global P&L experience and extensive background in mergers, acquisition integration, operations and international expansion are assets that will greatly benefit the company’s growth.”

Mr. Ball stated, "I am extremely excited about joining Solulink as their CEO. Solulink has a long legacy for innovation and has all the components necessary to be successful in today's highly competitive and rapidly growing life science markets. I look forward to leading the organization as Solulink introduces and commercializes its powerful HybriLink technology worldwide."

About Solulink

Solulink, a privately-held life science tools company, develops, manufactures and markets proprietary, next generation linking technology for the development and improvement of products in the research assay and diagnostic markets. Solulink’s latest innovation, the HybriLink Technology, improves the capabilities of end users, developers and suppliers to utilize the growing wide variety of detection technologies for research and diagnostic life science assays. Solulink markets their products directly and through distributors and licensing partners world-wide.

Contact

Solulink, Incorporated

Steve DeGraw

President

9853 Pacific Heights Blvd. Suite H

San Diego, California 92121

T 858.625.0670

F 858.625.0770

sdegraw@solulink.com

solulink@solulink.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES